Vident Investment Advisory’s Community Healthcare Trust CHCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,308
Closed -$406K 192
2023
Q2
$406K Buy
12,308
+336
+3% +$11.7K 0.01% 757
2023
Q1
$438K Sell
11,972
-349
-3% -$13.6K 0.01% 821
2022
Q4
$441K Buy
12,321
+152
+1% +$5.18K 0.02% 758
2022
Q3
$399K Buy
12,169
+2,530
+26% +$93.5K 0.01% 832
2022
Q2
$349K Sell
9,639
-118
-1% -$4.42K 0.01% 957
2022
Q1
$412K Buy
9,757
+1,984
+26% +$85.9K 0.01% 989
2021
Q4
$367K Buy
7,773
+94
+1% +$4.32K 0.01% 1006
2021
Q3
$347K Buy
7,679
+268
+4% +$13K 0.01% 968
2021
Q2
$352K Buy
7,411
+180
+2% +$8.81K 0.01% 912
2021
Q1
$333K Sell
7,231
-2,973
-29% -$138K 0.01% 893
2020
Q4
$481K Hold
10,204
0.02% 729
2020
Q3
$477K Buy
10,204
+4,090
+67% +$187K 0.02% 677
2020
Q2
$250K Sell
6,114
-623
-9% -$23.3K 0.01% 792
2020
Q1
$258K Sell
6,737
-280
-4% -$12.2K 0.02% 709
2019
Q4
$301K Buy
+7,017
New +$320K 0.02% 643

Other funds holding CHCT

Vident Investment Advisory's CHCT Position: Q3 2023 in Review

Vident Investment Advisory sold out of Community Healthcare Trust (CHCT) in Q3 2023, closing a stake of 12,308 shares — an estimated $406K sold.

Vident Investment Advisory first reported a position in CHCT in Q4 2019 and held it in 15 quarters. The position peaked at $481K in Q4 2020. 189 funds tracked by Wall St. Rank hold CHCT as of Q3 2023.

  • Vident Investment Advisory reported no remaining Community Healthcare Trust position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 12,308 Community Healthcare Trust shares in Q3 2023, an estimated $406K.
  • Vident Investment Advisory first reported a position in Community Healthcare Trust in Q4 2019 and held it in 15 quarters.
  • Vident Investment Advisory's Community Healthcare Trust position peaked at $481K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.